基层医疗机构慢性阻塞性肺疾病(慢阻肺)诊疗及管理现状调查研究

注册号:

Registration number:

ChiCTR2600121163 

最近更新日期:

Date of Last Refreshed on:

2026-03-26 11:13:53 

注册时间:

Date of Registration:

2026-03-26 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

基层医疗机构慢性阻塞性肺疾病(慢阻肺)诊疗及管理现状调查研究

Public title:

Investigation and Research on the Current Situation of Diagnosis, Treatment and Management of Chronic Obstructive Pulmonary Disease (COPD) in Primary Medical Institutions

注册题目简写:

English Acronym:

研究课题的正式科学名称:

基层医疗机构慢性阻塞性肺疾病(慢阻肺)诊疗及管理现状调查研究

Scientific title:

Investigation and Research on the Current Situation of Diagnosis, Treatment and Management of COPD in Primary Medical Institutions

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

彭雨昕 

研究负责人:

刘莎 

Applicant:

Yuxin Peng  

Study leader:

Sha Liu  

申请注册联系人电话:

Applicant telephone:

+86 187 7403 0393

研究负责人电话:

Study leader's
telephone:

+86 135 4442 5400

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

1628266913@qq.com

研究负责人电子邮件:

Study leader's E-mail:

liushadf@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

湖南省衡阳市蒸湘区解放大道35号

研究负责人通讯地址:

湖南省衡阳市蒸湘区解放大道35号

Applicant address:

No. 35, Jiefang Avenue, Zhengxiang District, Hengyang City, Hunan Province

Study leader's address:

No. 35, Jiefang Avenue, Zhengxiang District, Hengyang City, Hunan Province

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

南华大学附属第二医院

Applicant's institution:

The Second Affiliated Hospital of Nanhu University

研究负责人所在单位:

南华大学附属第二医院

Affiliation of the Leader:

The Second Affiliated Hospital of Nanhu University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

伦审快(2025108)号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

南华大学附属第二医院临床研究伦理审查委员会

Name of the ethic committee:

The Clinical Research Ethics Review Committee of the Second Hospital Affiliated to Nan Nan Hua University

伦理委员会批准日期:

Date of approved by ethic committee:

2025-12-17 00:00:00

伦理委员会联系人:

侯凯

Contact Name of the ethic committee:

Kai Hou

伦理委员会联系地址:

湖南省衡阳市蒸湘区解放大道35号

Contact Address of the ethic committee:

No. 35, Jiefang Avenue, Zhengxiang District, Hengyang City, Hunan Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 734 889 9767

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

南华大学附属第二医院

Primary sponsor:

The Second Affiliated Hospital of University of South China

研究实施负责(组长)单位地址:

湖南省衡阳市蒸湘区解放大道35号

Primary sponsor's address:

No. 35, Jiefang Avenue, Zhengxiang District, Hengyang City, Hunan Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

湖南

市(区县):

衡阳市

Country:

China

Province:

Hengyang

City:

Hengyang

单位(医院):

南华大学附属第二医院

具体地址:

湖南省衡阳市蒸湘区解放大道35号

Institution
hospital:

The Second Affiliated Hospital of Nanhu University

Address:

No. 35, Jiefang Avenue, Zhengxiang District, Hengyang City, Hunan Province

经费或物资来源:

个人和科室

Source(s) of funding:

Individuals and departments

研究疾病:

慢性阻塞性肺疾病  

Target disease:

chronic obstructive pulmonary disease

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

横断面 

Study design:

Cross-sectional 

研究目的:

全面了解衡阳市基层医疗机构在慢阻肺预防、筛查、诊断、治疗、管理及健康教育等方面的现状,明确其优势与面临的挑战;收集基层医务工作者对慢阻肺公卫项目政策支持的需求,为卫生行政部门优化基层慢阻肺防治策略、合理配置医疗资源、完善培训体系提供科学依据,进而提升区域内基层慢阻肺防治水平,惠及广大慢阻肺患者。  

Objectives of Study:

Comprehensively understand the current situation of grassroots medical institutions in Hengyang City in terms of prevention, screening, diagnosis, treatment, management and health education of chronic obstructive pulmonary disease (COPD), and clarify their advantages and challenges; collect the demands of grassroots medical workers for policy support for the public health project on COPD, to provide a scientific basis for the health administrative department to optimize the prevention and treatment strategies for COPD at the grassroots level, rationally allocate medical resources, and improve the training system, thereby enhancing the prevention and treatment level of COPD at the grassroots level in the region and benefiting the vast number of COPD patients.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

不在衡阳市基层医疗机构工作的人员。工作内容与慢阻肺诊疗、管理无关的人员。因认知障碍、语言障碍等无法独立完成问卷填写的人员。 明确拒绝参与本次研究的人员。

Exclusion criteria:

Those who do not work in the grassroots medical institutions of Hengyang City. Those whose job duties have nothing to do with the diagnosis and management of chronic obstructive pulmonary disease. Those who are unable to independently complete the questionnaire due to cognitive or language impairments. Clear. Those who explicitly refused to participate in this study.

研究实施时间:

Study execute time:

From 2026-04-01 00:00:00 To 2029-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2026-04-01 00:00:00 To 2029-12-31 00:00:00

干预措施:

Interventions:

组别:

现状调查

样本量:

500

Group:

status survey

Sample size:

干预措施:

干预措施代码:

Intervention:

none

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

衡阳市 

市(区县):

 

Country:

China

Province:

Hengyang City

City:

单位(医院):

南华大学附属第二医院 

单位级别:

三甲 

Institution
hospital:

The Second Affiliated Hospital of Nanhu University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

肺功能仪器配备率

指标类型:

主要指标

Outcome:

The equipment rate of pulmonary function instruments

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

疾病知晓率

指标类型:

主要指标

Outcome:

Disease awareness rate

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

肺功能开展率

指标类型:

主要指标

Outcome:

The rate of pulmonary function development

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 20 years
最大 Max age 65 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

1.数据采集: 使用“问卷星”或类似平台制作电子问卷,或发放统一格式的 纸质问卷。 2. 数据库建立与录入: 使用 EpiData 或 Excel 建立数据库。电子数据直接导 出,纸质问卷由经过培训的研究人员采用双人独立录入方式进行录入,并 进行一致性校验。 3. 数据存档: 所有电子数据存储在机构配备的、有密码保护的计算机中。纸 质问卷保存于南华大学附属第二医院呼吸科教研室的上锁文件柜中。研究 结束后,数据将继续保密保存 5 年以备核查。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Data collection: Use "Questionnaire Star" or similar platforms to create electronic questionnaires, or distribute uniform-format paper questionnaires. 2. Database establishment and entry: Use EpiData or Excel to establish the database. Electronic data are directly exported, and the paper questionnaires are entered by trained researchers using a double-person independent entry method and consistency verification is conducted. 3. Data archiving: All electronic data are stored in password-protected computers equipped by the institution. Paper questionnaires are kept in the locked filing cabinet of the Respiratory Department Teaching and Research Room of the Second Affiliated Hospital of South China University of Technology. After the study is completed, the data will be kept confidentially for another 5 years for verification purposes.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2026-03-26 11:13:30